She has spent the last five years as a Senior Finance Associate at Great Hill Partners. Drew Biedermann is an Associate with the TechAtlas division of RA Capital Management. He holds a BA in Neuroscience with a minor in Molecular and Cellular Biology from Colorado College. Angela also gained experience in prior roles as Clinical Trial Manager at Roche, Sarepta, and other companies, and Clinical Research Coordinator at Tufts Medical Center and Dana-Farber Cancer Institute. Age 46 / Jul 1976. Jaimie holds a BA in Biology Boston College, with Minors in Medical Humanities and Sociology, and a Master of Public Health from Boston University School of Public Health. Finally, they made it to the Boston. Walter has a BS in Biology from Davidson College and a MS in Genetics from University of Georgia. Cosmas received his BS in Physics from Massachusetts Institute of Technology and his MD from Rutgers-New Jersey Medical School. Neil Buckley is an EIR at RA Capital. Jake works on both public and private investments and serves as a Board Director for Xenikos, B.V, Tyra Biosciences, AavantiBio, and DiCE Molecules. His primary responsibilities are to assist with accounting, financial reporting and investment valuation. He is the co-inventor of first-in-class HCV NS5A inhibitors, which led to the approval of DaklinzaTM, the first marketed drug in its class. Sarah teaches a course at Harvard Law School on venture capital fund formation. Most recently, Tom served as Director of Operations at TPRV Capital, LP. Sri Mahendra is a Senior Software Engineer at RA Capital Management. Peter Kolchinsky on Twitter Milind attended the residential Executive Program at The Wharton School of Management. Americas +1 212 318 2000. (L-R) Robert Morgan, Jamie Anderson and Mark Blutman, collaborators on forthcoming 'Arigato Tokyo' Courtesy/Getty. He continues advising both in a consultant capacity. Prior to RA, Drew gained experience in Data Science in Technical Consultant roles at ExxonMobil. Sophie was a principal investigator in the Early Phase Trials Team at GSTT and has extensive experience in the delivery of early to late phase oncology trials. Kaleens primary responsibility is to oversee the initiation, planning, and execution of various projects within the TechAtlas Division. Kolchinsky is a founder and Managing Partner of RA Capital Management, L.P., a multi-stage investment manager which is dedicated to evidence-based investing in healthcare and life science companies that are developing drugs, medical devices, and diagnostics, where he has worked since 2001. Adisons primary responsibilities are to coordinate calendars, events, and company meetings for the Investment Team. Mario is responsible for partnering with several of our portfolio companies as Board Member or Technical Advisor. Gunes Bozkurt is an Analyst on the Venture Team at RA Capital Management. Kat Riesen is the VP, Finance at RA Ventures (RAVen). Les primary responsibility is to coordinate various technology related initiatives across the company. He was also a Board Member of the Fannie & John Hertz Foundation and served as a judge for the Lemelson-MIT StudentPrize for Inventorship. The market worked. He is a member of the Advisory Boards of the Applied Biotechnology Laboratory at the Francis Crick Institute, the Center for Surgery,Innovation & Bioengineering at the Massachusetts General Hospital/Harvard MedicalSchool; the Chemical& Biomolecular Engineering Department of the University of Illinois and the Biomedical Engineering Departmentof Rutgers University. Christina is a Senior Science Writer at RA Capital Management. Derek works on both public and private investments and serves as a Board Director for 89Bio, Achilles Therapeutics, iTeos Therapeutics, Connect Bio, CANbridge, andWerewolf Therapeutics. Mariagrace has a BS in Sociology from Suffolk University. Most recently, Joe led the administration and support of all Apple products at Curriculum Associates as an IT Systems Engineer. Peter Kolchinsky, Ph.D. is a biotechnology investor and a scientist. PETER KOLCHINSKY, PhD Managing Partner RAJEEV SHAH Managing Partner ANDREW LEVIN, MD/PhD Partner and Managing Director JOSH RESNICK, MD Senior Managing Director PETER BALOGH Analyst GUNES BOZKURT, PhD Analyst TESS CAMERON Principal NATE DAVIS Analyst DEREK DiROCCO, PhD Partner CRISTINA GHENOIU, PhD Principal MICHAEL GILLESPIE, MD Analyst Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. Zach Scheiner is a Principal on the Investment Team at RA Capital Management. Bio Peter Kolchinsky James primary responsibilities are to advise RA Capital on public and private investments, coordinate with portfolio companies regarding deal structures and terms, and provide counsel and oversight on regulatory matters. I would love to talk to the 1 out of 7 VCs who thinks non-orphan small molecules for older patients are just as investable post Raj previously worked as a Senior Project Leader at Altus Pharmaceuticals, a spin-off company of Vertex Pharmaceuticals, where he assessed business processes and implemented system solutions across all areas of science. Previously in his career, he served as Associate General Counsel at Millennium Pharmaceuticals (now Takeda Oncology) where he built the legal department and led internal legal activities supporting several transformative pharmaceutical partnerships, a substantial global patent estate, and the companys IPO. Peter Pan & Wendy supports the theory that Peter Pan is the real villain of his respective franchise with its depiction of the beloved Disney character. Peter also leads the firms engagement and publishing efforts, which aim to make a positive social impact and spark collaboration among healthcare stakeholders, including patients, physicians, researchers, policymakers, and industry. Prior to RA, she served as Researcher and Collaborator at New Care, a startup focused on improving access to early childcare for lower income families. Tim began his career at Merck & Co., serving in multiple commercial roles in its cardiovascular, gastrointestinal, and managed care divisions. Peter Kolchinsky Number of IPOs: 18. David holds a PhD from Harvard University in Biophysics and a BS in Molecular Biology from Texas A&M University. Jenna Hebert is an Associate within the TechAtlas division of RA Capital Management. Brigid holds a BS in Chemistry (Hons) from the Commonwealth Honors College at the University of Massachusetts, Amherst (2002) and a PhD in Materials Science and Engineering from Johns Hopkins University (2009). Sonia Kartha is an Associate with the TechAtlas division of RA Capital Management. He completed an internship in Internal Medicine and residency in Psychiatry at the University of Utah Health Sciences Center. Megan Lipcsey is an Associate with the TechAtlas division of RA Capital Management. Dans primary responsibility at RA Capital is to identify compelling opportunities to help facilitate new company creation or investments in emerging seed-stage companies. However he's a bit older than others, like Raquel Leviss, who is only 28 . Prior to joining RA Capital, Jeff worked for over 10 years as an institutional equity sales trader, primarily at KCG Holdings, Inc., where he managed the Boston office. His graduate research investigated the role of fimbria in Bordetella adherence and virulence. Let us know if you like it and we may post more pieces with this option.) Shan Shans primary responsibilities are to drive internal and external strategic and diligence initiatives and oversee the workflow and professional development of TechAtlas Associates. Prior to RA, Laura was a Principal at MP Healthcare Venture Management. Prior to joining RA, Kathryn was SVP of Strategy at Energetic Insurance where she addressed regulatory-driven commercial lender limitations to enable financing for renewable energy and efficiency via financial insurance products. He previously held roles as VP Product Manager - Data Services at Charles River Development (a State Street Company) and Senior Business Analyst in Capital Markets at Bain Capital Credit and State Street Global Exchange, DataGX. Alonso completed his Ph.D. in Chemistry at the University of Florida and his post-doctoral work as a Howard Hughes Medical Institute Fellow at Harvard University and the Massachusetts General Hospital. He was also the co-founder and President of Research and Development of Cydan, a rare disease accelerator. Erichs primary responsibilities are to drive internal and external strategic and diligence initiatives and oversee the workflow and professional development of TechAtlas Associates. Jaimie's primary responsibility is to conduct research and analysis for competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. She is a CPA. Ross has a BS in Biochemistry from University of Oregon and a PhD in Pharmacology & Molecular Sciences from Johns Hopkins University. Emorys primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Matt comes to RA from Localytics where he served as a Senior Software Engineer for the past two years. Max DeNies is a Senior Associate with the TechAtlas division of RA Capital Management. Merediths primary responsibility is to conduct research and analysis for competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. Ramin Farzaneh-Far is a Venture Partner at RA Capital where he works closely with RAs Venture Team to evaluate drug discovery platforms and initiate novel therapeutics programs. Sadik holds a bachelor of science degree in Cell and Molecular Biology from Tulane University, and earned his PhD in Microbiology and Immunology from Louisiana State University. Tim received his A.B. Lucas primary responsibilities are to advise on regulatory matters and assist in the development, implementation, and testing of the compliance program. Katherine Terranova is an Associate within the TechAtlas division of RA Capital Management. Pieter has been recognized as one of the outstanding leaders in the U.S. through his selection as a White House Fellow, and he currently serves on the Board of Directors of the White House Fellows Foundation. Peter Kolchinsky - Biography - MarketScreener.com Earlier in his career, he was Head of Early Analytical Development for Novartis Cell and Gene Therapies Unit and worked on research teams at the National Cancer Institute with Dr. Steven Rosenberg, the University of Pennsylvania Gene Therapy Program with Dr. Jim Wilson, and Johnson and Johnsons Immunology Discovery group. Prior to Akebia, she gained Administrative and Resource Management experience at Wellington Management and Signature Consultants, respectively. Previously, Jake covered solid tumor oncology landscapes. Prior to Proteros, Cony was Senior Vice President, Business Development, North America for Evotec and was responsible for managing all commercial activities of Evotec in North America. Tylers primary responsibility at RA Capital isdesigning and maintaining the RA Capital website and assisting in the creation and design of interactive platforms at RA Capital and it's portfolio companies founded through the firm's incubator, RA Ventures. Brian is a IT Operations Manager at RA Capital Management. Dan Guglielmo is IT Operations Associate at RA Capital Management. Gabes primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Chris has a BS in Neurobiology and Behavior from Cornell University and a MA in Journalism from New York University. Anas previous experience includes Research Assistant positions at Massachusetts Eye and Ear Hospital, the Lupus Clinic/Renal Department at the BU Medical Center, and Harvard University Department of Molecular and Cellular Biology. Erich Scheller is the Director of the TechAtlas division of RA Capital Management. They will discuss the origins and history . Cristina Montero is an Associate Director within the TechAtlas division of RA Capital Management. Prior to that, he was a Life Sciences Investment Associate at Brigham Capital.
Liberia To La Fortuna Driving,
How Many Wives Did Jerry Lee Lewis Have,
Michigan Noise Complaint,
Interesting Facts About Seti 1,
Rudy Solari Cause Of Death,
Articles P
